{"filing":{"accession_number":"0001729149-26-000034","cik":"0001729149","ticker":"VMD","company_name":"VIEMED HEALTHCARE, INC.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"vmd-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1729149/000172914926000034/vmd-20260604.htm"},"events":[{"id":7008,"run_id":6147,"accession_number":"0001729149-26-000034","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Shareholders approved four matters at the annual meeting: election of seven directors (79.76%–97.67%), appointment of Ernst \u0026 Young LLP as independent auditors (97.59%), approval of the Second Amendment to the 2024 Long Term Incentive Plan increasing reserved shares to 7,696,717 (88.85%), and an advisory say-on-pay vote (93.21%).","company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4564,"accession_number":"0001729149-26-000034","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of a Second Amendment to the 2024 Long Term Incentive Plan that increases the maximum number of common shares reserved for issuance under equity compensation plans to 7,696,717 shares. This is a material compensatory arrangement amendment affecting the pool of equity available for director and officer compensation, which is the core subject of Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:57.901685+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4565,"accession_number":"0001729149-26-000034","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from an annual shareholder meeting covering four matters: election of seven directors, appointment of Ernst \u0026 Young LLP as independent auditors, approval of the Second Amendment to the 2024 LTIP, and an advisory say-on-pay vote. All four proposals passed with substantial majorities (ranging from 79.76% to 97.67% for director elections, 97.59% for auditor appointment, 88.85% for the compensation plan amendment, and 93.21% for the say-on-pay vote), which is material to investors assessing corporate governance and management accountability.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:57.901685+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4564,"accession_number":"0001729149-26-000034","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of a Second Amendment to the 2024 Long Term Incentive Plan that increases the maximum number of common shares reserved for issuance under equity compensation plans to 7,696,717 shares. This is a material compensatory arrangement amendment affecting the pool of equity available for director and officer compensation, which is the core subject of Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:57.901685+00:00","company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","filing_date":"2026-06-04"},{"id":4565,"accession_number":"0001729149-26-000034","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from an annual shareholder meeting covering four matters: election of seven directors, appointment of Ernst \u0026 Young LLP as independent auditors, approval of the Second Amendment to the 2024 LTIP, and an advisory say-on-pay vote. All four proposals passed with substantial majorities (ranging from 79.76% to 97.67% for director elections, 97.59% for auditor appointment, 88.85% for the compensation plan amendment, and 93.21% for the say-on-pay vote), which is material to investors assessing corporate governance and management accountability.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:27:57.901685+00:00","company_name":"VIEMED HEALTHCARE, INC.","ticker":"VMD","filing_date":"2026-06-04"}]}